Xenon Pharmaceuticals Inc. · NASDAQ:XENE
Wellington Management Group LLP reported a 6.20% stake in Xenon Pharmaceuticals Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 10, 2026
Wellington Management Group LLP reported a 6.20% stake in Xenon Pharmaceuticals Inc., 4,764,779 shares, as a passive investor on Dec 31, 2025. Filed Feb 10, 2026 (Schedule 13G).
- Stake
- 6.20%
- Shares
- 4,764,779
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wellington Management Group LLP | 6.20% | 4,764,779 |
| Wellington Group Holdings LLP | 6.20% | 4,764,779 |
| Wellington Investment Advisors Holdings LLP | 6.20% | 4,764,779 |
| Wellington Management Company LLP | 6.00% | 4,764,779 |
Source
Related
- Xenon Pharmaceuticals Inc.
- Wellington Management Group LLP
- Xenon Pharmaceuticals Inc. shareholders
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Schedule 13G/A · Wellington Management Group LLP · Aug 12, 2025
- Form 4 · Kelly Thomas Patrick · Oct 16, 2026
- Form 4 · Kelly Thomas Patrick · Oct 1, 2026
- Form 4 · Mortimer Ian · Oct 1, 2026
- Form 4 · Svoronos Dawn · Sep 3, 2026
- Form 4 · Kenney Christopher John · Aug 31, 2026